Drug Topics Hospital Pharmacists' Report

May 17, 2012

Web Version  |  Manage Your Profile  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Vitamin D threshold varies with season, study shows

Researchers from the University of Washington have identified a threshold concentration of serum 25-hydroxyvitamin D [25-(OH)D] that is associated with increased risk for major medical events and say that season-specific targets may be more appropriate than static targets when evaluating health risk. » More

Continuing Education

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Variation in schizophrenia treatment

Patients with schizophrenia who switched from haloperidol decanoate or fluphenazine decanoate to risperidone microspheres discontinued their treatment more frequently, according to a new study published in the March issue of the Journal of Clinical Psychiatry. » More

Study on schizophrenia deaths makes surprising find

A unique study designed to gauge the impact of polypharmacy on schizophrenia mortality produced some surprising results: The use of antidepressants or 2 or more antipsychotics was not associated with increased deaths, but the use of  benzodiazepine was. » More

Warfarin, aspirin similar in treating heart failure

Warfarin fared no better than aspirin at reducing the combined risk of brain hemorrhage, stroke, or death for heart-failure patients in normal rhythm, according to the results of a study published in the New England Journal of Medicine. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

Ending law may erode healthcare access

Helping impaired patients monitor diabetes

OTC naloxone? It's possible

Project RED helps lower readmission rates

Voices

Anticoagulation Update

JP at Large: Pharmacy’s own “1984”

View from the Zoo: Fox in the henhouse

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.